Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in North America. The aim of this clinical trial is to evaluate the
potential of liraglutide to maintain long term weight loss in obese non-diabetic subjects, as
well as in overweight subjects who have medical problems such as hypertension (high blood
pressure) or dyslipidaemia (an abnormal amount of lipids in the blood).
Trial has following trial periods: A 12-week run-in period (from week -12 to week 0) followed
by a 56-week main trial period (weeks 0-56) and a 12-week follow-up period (weeks 56-68).